AIM logo

AIM ImmunoTech (AIM) Working Capital

Annual Working Capital

$5.90 M
-$29.06 M-83.11%

31 December 2023

AIM Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

-$2.53 M
-$4.05 M-266.56%

30 September 2024

AIM Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AIM Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-83.1%-114.0%
3 y3 years-84.9%-106.8%
5 y5 years+495.4%-130.0%

AIM Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-88.1%at low-105.1%at low
5 y5 years-88.1%+495.4%-105.0%at low
alltimeall time-89.4%+495.4%-104.2%at low

AIM ImmunoTech Working Capital History

DateAnnualQuarterly
Sept 2024
-
-$2.53 M(-266.6%)
June 2024
-
$1.52 M(+6.2%)
Mar 2024
-
$1.43 M(-75.8%)
Dec 2023
$5.90 M(-83.1%)
$5.90 M(-67.2%)
Sept 2023
-
$18.03 M(-30.6%)
June 2023
-
$25.98 M(-17.0%)
Mar 2023
-
$31.32 M(-10.4%)
Dec 2022
$34.96 M(-29.4%)
$34.96 M(-8.6%)
Sept 2022
-
$38.26 M(-14.4%)
June 2022
-
$44.68 M(-10.0%)
Mar 2022
-
$49.61 M(+0.1%)
Dec 2021
$49.54 M(+26.4%)
$49.54 M(+32.9%)
Sept 2021
-
$37.27 M(-7.9%)
June 2021
-
$40.45 M(-19.5%)
Mar 2021
-
$50.25 M(+28.2%)
Dec 2020
$39.21 M(+320.7%)
$39.21 M(+0.6%)
Sept 2020
-
$38.96 M(+13.5%)
June 2020
-
$34.33 M(+18.4%)
Mar 2020
-
$29.01 M(+211.3%)
Dec 2019
$9.32 M(-724.2%)
$9.32 M(+10.5%)
Sept 2019
-
$8.43 M(+320.0%)
June 2019
-
$2.01 M(-46.7%)
Mar 2019
-
$3.77 M(-352.4%)
Dec 2018
-$1.49 M(-287.1%)
-$1.49 M(+7757.9%)
Sept 2018
-
-$19.00 K(-100.6%)
June 2018
-
$3.21 M(+6.5%)
Mar 2018
-
$3.01 M(+277.6%)
Dec 2017
$798.00 K(-82.3%)
$798.00 K(-48.0%)
Sept 2017
-
$1.53 M(-20.8%)
June 2017
-
$1.94 M(-24.2%)
Mar 2017
-
$2.55 M(-43.3%)
Dec 2016
$4.51 M(-44.6%)
$4.51 M(-34.7%)
Sept 2016
-
$6.90 M(+9.5%)
June 2016
-
$6.30 M(-2.2%)
Mar 2016
-
$6.45 M(-20.8%)
Dec 2015
$8.14 M(-32.6%)
$8.14 M(-23.6%)
Sept 2015
-
$10.65 M(-23.7%)
June 2015
-
$13.96 M(-1.0%)
Mar 2015
-
$14.10 M(+16.8%)
Dec 2014
$12.07 M(-24.7%)
$12.07 M(-10.0%)
Sept 2014
-
$13.41 M(-17.7%)
June 2014
-
$16.30 M(-13.8%)
Mar 2014
-
$18.90 M(+18.0%)
Dec 2013
$16.02 M(-50.1%)
$16.02 M(-15.3%)
Sept 2013
-
$18.92 M(-17.8%)
June 2013
-
$23.02 M(-19.4%)
Mar 2013
-
$28.55 M(-11.0%)
Dec 2012
$32.08 M(+20.1%)
$32.08 M(+20.3%)
Sept 2012
-
$26.66 M(+15.3%)
June 2012
-
$23.13 M(-16.4%)
Mar 2012
-
$27.66 M(+3.5%)
Dec 2011
$26.72 M(-21.1%)
$26.72 M(-12.7%)
Sept 2011
-
$30.62 M(-1.5%)
June 2011
-
$31.09 M(-8.1%)
Mar 2011
-
$33.84 M(0.0%)
Dec 2010
$33.84 M
$33.84 M(-6.5%)
Sept 2010
-
$36.19 M(+3.6%)
June 2010
-
$34.94 M(-32.2%)
DateAnnualQuarterly
Mar 2010
-
$51.53 M(-7.6%)
Dec 2009
$55.79 M(+888.1%)
$55.79 M(-8.1%)
Sept 2009
-
$60.69 M(+50.8%)
June 2009
-
$40.25 M(+850.9%)
Mar 2009
-
$4.23 M(-25.0%)
Dec 2008
$5.65 M(-60.8%)
$5.65 M(-17.5%)
Sept 2008
-
$6.84 M(-28.9%)
June 2008
-
$9.63 M(-19.0%)
Mar 2008
-
$11.89 M(-17.5%)
Dec 2007
$14.41 M(-13.0%)
$14.41 M(-13.4%)
Sept 2007
-
$16.63 M(-15.3%)
June 2007
-
$19.64 M(+1.9%)
Mar 2007
-
$19.29 M(+16.5%)
Dec 2006
$16.56 M(+1.3%)
$16.56 M(+24.8%)
Sept 2006
-
$13.27 M(-18.7%)
June 2006
-
$16.32 M(-30.4%)
Mar 2006
-
$23.44 M(+43.3%)
Dec 2005
$16.35 M(+3.9%)
$16.35 M(+105.3%)
Sept 2005
-
$7.97 M(-12.0%)
June 2005
-
$9.05 M(-22.4%)
Mar 2005
-
$11.67 M(-25.9%)
Dec 2004
$15.74 M(+124.9%)
$15.74 M(-10.8%)
Sept 2004
-
$17.65 M(+83.3%)
June 2004
-
$9.63 M(+67.1%)
Mar 2004
-
$5.76 M(-17.7%)
Dec 2003
$7.00 M(+139.3%)
$7.00 M(+16.8%)
Sept 2003
-
$5.99 M(+10.7%)
June 2003
-
$5.41 M(+32.9%)
Mar 2003
-
$4.07 M(+39.2%)
Dec 2002
$2.92 M(-61.2%)
$2.92 M(-16.0%)
Sept 2002
-
$3.48 M(-33.7%)
June 2002
-
$5.26 M(-14.9%)
Mar 2002
-
$6.17 M(-18.0%)
Dec 2001
$7.53 M(-0.2%)
$7.53 M(+136.7%)
Sept 2001
-
$3.18 M(-27.7%)
June 2001
-
$4.41 M(-19.6%)
Mar 2001
-
$5.48 M(-27.4%)
Dec 2000
$7.55 M(-20.5%)
$7.55 M(-11.7%)
Sept 2000
-
$8.55 M(-11.8%)
June 2000
-
$9.70 M(-13.1%)
Mar 2000
-
$11.16 M(+17.5%)
Dec 1999
$9.50 M(-24.6%)
$9.50 M(+63.8%)
Sept 1999
-
$5.80 M(-17.1%)
June 1999
-
$7.00 M(-26.3%)
Mar 1999
-
$9.50 M(-24.6%)
Dec 1998
$12.60 M(+35.5%)
$12.60 M(-13.7%)
Sept 1998
-
$14.60 M(+117.9%)
June 1998
-
$6.70 M(-16.3%)
Mar 1998
-
$8.00 M(-14.0%)
Dec 1997
$9.30 M(+116.3%)
$9.30 M(+1760.0%)
Sept 1997
-
$500.00 K(-75.0%)
June 1997
-
$2.00 M(-37.5%)
Mar 1997
-
$3.20 M(-25.6%)
Dec 1996
$4.30 M(+38.7%)
$4.30 M(-24.6%)
Sept 1996
-
$5.70 M(+375.0%)
June 1996
-
$1.20 M(-50.0%)
Mar 1996
-
$2.40 M(-22.6%)
Dec 1995
$3.10 M
$3.10 M

FAQ

  • What is AIM ImmunoTech annual working capital?
  • What is the all time high annual working capital for AIM ImmunoTech?
  • What is AIM ImmunoTech annual working capital year-on-year change?
  • What is AIM ImmunoTech quarterly working capital?
  • What is the all time high quarterly working capital for AIM ImmunoTech?
  • What is AIM ImmunoTech quarterly working capital year-on-year change?

What is AIM ImmunoTech annual working capital?

The current annual working capital of AIM is $5.90 M

What is the all time high annual working capital for AIM ImmunoTech?

AIM ImmunoTech all-time high annual working capital is $55.79 M

What is AIM ImmunoTech annual working capital year-on-year change?

Over the past year, AIM annual working capital has changed by -$29.06 M (-83.11%)

What is AIM ImmunoTech quarterly working capital?

The current quarterly working capital of AIM is -$2.53 M

What is the all time high quarterly working capital for AIM ImmunoTech?

AIM ImmunoTech all-time high quarterly working capital is $60.69 M

What is AIM ImmunoTech quarterly working capital year-on-year change?

Over the past year, AIM quarterly working capital has changed by -$20.56 M (-114.04%)